KCM
BSX icon

Key Capital Management’s Boston Scientific BSX Stock Holding History

Key Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23
Closed -$1.44K – 741
2026
Q1 		$1.44K Buy
+23
New +$1.84K ﹤0.01% 574

Other funds holding BSX

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Key Capital Management's BSX Position: Q2 2026 in Review

Key Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 23 shares — an estimated $1.44K sold.

Key Capital Management first reported a position in BSX in Q1 2026 and held it in 1 quarter. The position peaked at $1.44K in Q1 2026. 712 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Key Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Key Capital Management sold 23 Boston Scientific shares in Q2 2026, an estimated $1.44K.
  • Key Capital Management first reported a position in Boston Scientific in Q1 2026 and held it in 1 quarter.
  • Key Capital Management's Boston Scientific position peaked at $1.44K in Q1 2026.
  • 712 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Key Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.